NFKB1 and hyperlipidemia: In the current study, α-Man was discovered to ameliorate aging-related adiposity, hyperlipidemia, insulin resistance and liver injury by alleviating adipose tissue inflammation, possibly through inhibiting NF-κB and MAPKs signaling pathways.